Literature DB >> 25363284

Genetics Health Professionals' Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools.

M Paneque1, Á Mendes, L Guimarães, J Sequeiros, H Skirton.   

Abstract

Quality assessment of genetic counseling practice for improving healthcare is a challenge for genetic services worldwide; however, there is scarce literature regarding quality issues in genetic counseling in the context of presymptomatic testing for late-onset neurological diseases (Paneque et al. 2012) The aims of this qualitative study were to: (1) explore the views of professionals' who provide genetic counseling services for presymptomatic testing for late-onset neurological diseases regarding relevant quality indicators for counseling practice; and (2) examine current assessment of such counseling practice for Portuguese genetic services. Quality indicators are a means of measuring either the process or outcomes of patient services, with the aim of evaluating and improving quality of care (Mainz 2003). In this study, we defined quality indicators as measurable outcomes of the counseling process that may reflect good professional practice and desirable end-term effects. We undertook interviews with 18 genetic health professionals (85 % of all genetic counseling professionals involved) from the major genetic services in Portugal. Results indicate that professionals valued some core components of genetic counseling, including providing information and decision-making support, informing the consultand about the genetic counseling protocol, as well as exploring motivations, expectations for test results, consequent anticipated life changes, psychosocial adjustment, and personal and familial experience with the disease. Professionals were not, however, able to clearly elucidate quality indicators for effective practice and some reported they had not reflected on that topic before. Professionals also reported specific challenges in their practice, such as ambiguity of the health/illness status and affirming consultands' autonomy. Results of the study have revealed a lack of knowledge about quality indicators and tools to assess counseling practice. A credible set of quality indicators for presymptomatic testing is required as a foundation for the development of specific tools.

Entities:  

Mesh:

Year:  2014        PMID: 25363284     DOI: 10.1007/s10897-014-9784-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  38 in total

1.  Psychological studies in Huntington's disease: making up the balance.

Authors:  M Duisterhof; R W Trijsburg; M F Niermeijer; R A Roos; A Tibben
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

2.  Defining and classifying clinical indicators for quality improvement.

Authors:  Jan Mainz
Journal:  Int J Qual Health Care       Date:  2003-12       Impact factor: 2.038

Review 3.  How risk is perceived, constructed and interpreted by clients in clinical genetics, and the effects on decision making: systematic review.

Authors:  Stephanie Sivell; Glyn Elwyn; Clara L Gaff; Angus J Clarke; Rachel Iredale; Chris Shaw; Joanna Dundon; Hazel Thornton; Adrian Edwards
Journal:  J Genet Couns       Date:  2007-10-30       Impact factor: 2.537

4.  Coming full circle: a reciprocal-engagement model of genetic counseling practice.

Authors:  Patricia McCarthy Veach; Dianne M Bartels; Bonnie S Leroy
Journal:  J Genet Couns       Date:  2007-10-13       Impact factor: 2.537

5.  Identification and prioritization of quality indicators in clinical genetics: an international survey.

Authors:  Barbara C Zellerino; Sharon A Milligan; Jonathon R Gray; Marc S Williams; Ron Brooks
Journal:  Am J Med Genet C Semin Med Genet       Date:  2009-08-15       Impact factor: 3.908

Review 6.  Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles.

Authors:  Milena Paneque; Jorge Sequeiros; Heather Skirton
Journal:  Genet Test Mol Biomarkers       Date:  2011-08-05

7.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

8.  What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective.

Authors:  Lídia Guimarães; Jorge Sequeiros; Heather Skirton; Milena Paneque
Journal:  J Genet Couns       Date:  2013-01-07       Impact factor: 2.537

9.  Clinicians and outcome measurement: what's the use?

Authors:  Ann F Garland; Marc Kruse; Gregory A Aarons
Journal:  J Behav Health Serv Res       Date:  2003 Oct-Dec       Impact factor: 1.505

10.  The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from.

Authors:  T Cruz-Mariño; L Velázquez-Pérez; Y González-Zaldivar; R Aguilera-Rodríguez; M Velázquez-Santos; Y Vázquez-Mojena; A Estupiñán-Rodríguez; J M Laffita-Mesa; R Reynaldo-Armiñán; L E Almaguer-Mederos; M Paneque
Journal:  Clin Genet       Date:  2013-06       Impact factor: 4.438

View more
  5 in total

1.  Genetic Counseling in Portugal: Education, Practice and a Developing Profession.

Authors:  Milena Paneque; Álvaro Mendes; Jorge Saraiva; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2015-03-03       Impact factor: 2.537

2.  The Contribution of the Reciprocal-Engagement Model as a Theoretical Framework of a Portuguese Scale for Quality Assessment of Genetic Counseling.

Authors:  C Costa; M S Lemos; Milena Paneque
Journal:  J Genet Couns       Date:  2018-06-25       Impact factor: 2.537

3.  SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.

Authors:  Tania Cruz-Mariño; Yaimeé Vázquez-Mojena; Luis Velázquez-Pérez; Yanetza González-Zaldívar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Annelié Estupiñán-Rodríguez; José Miguel Laffita-Mesa; Luis E Almaguer-Mederos; Milena Paneque
Journal:  J Community Genet       Date:  2015-04-19

Review 4.  Genetic counseling and testing practices for late-onset neurodegenerative disease: a systematic review.

Authors:  Ashley Crook; Chris Jacobs; Toby Newton-John; Rosie O'Shea; Alison McEwen
Journal:  J Neurol       Date:  2021-03-01       Impact factor: 6.682

Review 5.  Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.

Authors:  Laura Obici; Jan B Kuks; Juan Buades; David Adams; Ole B Suhr; Teresa Coelho; Theodore Kyriakides
Journal:  Curr Opin Neurol       Date:  2016-02       Impact factor: 5.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.